Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure.

Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation. J Mol Cell Cardiol (2009) 1.06

Eplerenone: the evidence for its place in the treatment of heart failure after myocardial infarction. Core Evid (2005) 0.75

Management of the Cirrhotic Patient Before Liver Transplantation: The Role of the Referring Gastroenterologist. Gastroenterol Hepatol (N Y) (2006) 0.75

Primary aldosteronism: a common cause of resistant hypertension. CMAJ (2017) 0.75

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.27

Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest (2006) 3.54

Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol (2011) 1.40

Accuracy and pharmacist perceptions of community-based automated blood pressure machines. J Am Pharm Assoc (2003) (2011) 1.38

Role of vitamin D in cardiovascular health. Am J Cardiol (2010) 1.26

Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke (2004) 1.23

Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance. Ann Pharmacother (2008) 1.04

Does simvastatin cause more myotoxicity compared with other statins? Ann Pharmacother (2009) 0.90

Role of C-reactive protein in cardiovascular disease. Ann Pharmacother (2004) 0.87

Optimal lipid modification: the rationale for combination therapy. Vasc Health Risk Manag (2005) 0.82

Association of HMG-CoA reductase inhibitors with neuropathy. Ann Pharmacother (2003) 0.81

Community pharmacy-based medication therapy management services: financial impact for patients. Pharm Pract (Granada) (2012) 0.78

Study of nonparticipation in an employee diabetes program. J Am Pharm Assoc (2003) (2012) 0.78

Do ACE Inhibitors/Angiotensin II type 1 receptor antagonists reduce hospitalisations in older patients with heart failure? A propensity analysis. Drugs Aging (2007) 0.77

Risk-stratified evaluation of amiodarone to prevent atrial fibrillation after cardiac surgery. Ann Thorac Surg (2006) 0.76

New treatment guidelines for unstable angina/non-ST-segment elevation myocardial infartion. Ann Pharmacother (2002) 0.75

Do statins have a role in the management of diastolic dysfunction? Am J Cardiovasc Drugs (2008) 0.75

P2Y₁₂ receptor inhibitors: integrating ticagrelor into the management of acute coronary syndrome. Ann Pharmacother (2011) 0.75

High-impact articles related to the pharmacotherapeutic management of systolic heart failure. Pharmacotherapy (2004) 0.75